More than half of insured Americans say they can't predict how much their covered prescription drugs will cost, according to an annual survey by the pharmaceutical industry trade group PhRMA. The results, shared first with Axios, come as the drug industry is pressing for more transparency regulations on pharmacy benefit managers and insurers in the lame-duck period following the election.
